Skip to main content
Erschienen in: Supportive Care in Cancer 9/2011

01.09.2011 | Case Study

Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage)

verfasst von: Joan Elizabeth Cunningham, Teresa Kelechi, Katherine Sterba, Nikki Barthelemy, Paul Falkowski, Steve H. Chin

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, miserable, potentially severe, and often dose-limiting side effect of several first and second-line anti-cancer agents with little in the way of effective, acceptable treatment. Although mechanisms of damage differ, manual therapy (therapeutic massage) has effectively reduced symptoms and improved quality of life in patients with diabetic peripheral neuropathy.

Methods

Here, we describe application of manual therapy (techniques of effleurage and petrissage) to the extremities in a patient with grade 2 CIPN subsequent to prior treatment with docetaxel and cisplatin for stage III esophageal adenocarcinoma. Superficial cutaneous temperature was monitored using infrared thermistry as proxy for microvascular blood flow.

Results

By the end of the course of manual therapy without any change in medications, CIPN symptoms were greatly reduced to grade 1, with corresponding improvement in quality of life. Improvements in superficial temperature were observed in fingers and toes.

Conclusions

Manual therapy was associated with almost complete resolution of the tingling and numbness and pain of CIPN in this patient. Concurrently increased superficial temperature suggests improvements in CIPN symptoms may have involved changes in blood circulation. To our knowledge, this is the first report of using manual therapy for amelioration of CIPN.
Literatur
1.
Zurück zum Zitat Gutiérrez-Gutiérrez G, Sereno M, Miralles A, Casado-Sáenz E, Gutiérrez-Rivas E (2010) Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clin Transl Oncol 12(2):81–91PubMedCrossRef Gutiérrez-Gutiérrez G, Sereno M, Miralles A, Casado-Sáenz E, Gutiérrez-Rivas E (2010) Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies. Clin Transl Oncol 12(2):81–91PubMedCrossRef
2.
Zurück zum Zitat Cavaletti G, Marmiroli P (2010) Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6:657–666PubMedCrossRef Cavaletti G, Marmiroli P (2010) Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6:657–666PubMedCrossRef
3.
Zurück zum Zitat Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede R-D, Turk CD, Wallace MS (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237–251PubMedCrossRef Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede R-D, Turk CD, Wallace MS (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237–251PubMedCrossRef
4.
Zurück zum Zitat Kaley TJ, DeAngelis LM (2009) Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol 145:3–14PubMedCrossRef Kaley TJ, DeAngelis LM (2009) Therapy of chemotherapy-induced peripheral neuropathy. Br J Haematol 145:3–14PubMedCrossRef
5.
Zurück zum Zitat Postma TJ, Heimans JJ (2000) Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol 11:509–513PubMedCrossRef Postma TJ, Heimans JJ (2000) Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol 11:509–513PubMedCrossRef
6.
Zurück zum Zitat Lee JJ, Low JA, Croarkin E, Parks R, Berman AW, Mannan N, Steinberg SM, Swain SM (2006) Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone. J Clin Oncol 24:2084–2091PubMedCrossRef Lee JJ, Low JA, Croarkin E, Parks R, Berman AW, Mannan N, Steinberg SM, Swain SM (2006) Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone. J Clin Oncol 24:2084–2091PubMedCrossRef
8.
Zurück zum Zitat Mielke S, Sparreboom A, Mross K (2006) Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. Eur J Cancer 42:24–30PubMedCrossRef Mielke S, Sparreboom A, Mross K (2006) Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. Eur J Cancer 42:24–30PubMedCrossRef
9.
Zurück zum Zitat Hartmann JT, Lipp HP (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4:889–901PubMedCrossRef Hartmann JT, Lipp HP (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4:889–901PubMedCrossRef
10.
Zurück zum Zitat Kim GP, Erlichman C (2007) Oxaliplatin in the treatment of colorectal cancer. Expert Opin Drug Metab Toxicol 3:281–294PubMedCrossRef Kim GP, Erlichman C (2007) Oxaliplatin in the treatment of colorectal cancer. Expert Opin Drug Metab Toxicol 3:281–294PubMedCrossRef
11.
Zurück zum Zitat Argyriou AA, Polychronopoulos P, Iconomou G, Koutras A, Makatsoris T, Gerolymos MK, Gourzis P, Assimakopoulos K, Kalofonos HP, Chroni E (2007) Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer. Acta Oncol 46:1131–1137PubMedCrossRef Argyriou AA, Polychronopoulos P, Iconomou G, Koutras A, Makatsoris T, Gerolymos MK, Gourzis P, Assimakopoulos K, Kalofonos HP, Chroni E (2007) Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer. Acta Oncol 46:1131–1137PubMedCrossRef
12.
Zurück zum Zitat Velasco R, Bruna J (2010) Chemotherapy-induced peripheral neuropathy: an unresolved issue. Neurologia 25(2):116–131PubMed Velasco R, Bruna J (2010) Chemotherapy-induced peripheral neuropathy: an unresolved issue. Neurologia 25(2):116–131PubMed
13.
Zurück zum Zitat Park SB, Krishnan AV, Lin CS-Y, Goldstein D, Friedlander M, Kiernan MC (2008) Mechanisms underlying chemotherapy induced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem 15(29):3081–3094PubMedCrossRef Park SB, Krishnan AV, Lin CS-Y, Goldstein D, Friedlander M, Kiernan MC (2008) Mechanisms underlying chemotherapy induced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem 15(29):3081–3094PubMedCrossRef
14.
Zurück zum Zitat Bullinger KL, Nardelli P, Quingbo W, Rich MM, Cope TC (2011) Oxaliplatin neurotoxicity of sensory transduction in rat proprioceptors. J Neurophysiol. doi:10.1152/jn.00083.2011 Bullinger KL, Nardelli P, Quingbo W, Rich MM, Cope TC (2011) Oxaliplatin neurotoxicity of sensory transduction in rat proprioceptors. J Neurophysiol. doi:10.​1152/​jn.​00083.​2011
16.
Zurück zum Zitat Cassileth BR, Vickers AJ (2004) Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage 28:244–249PubMedCrossRef Cassileth BR, Vickers AJ (2004) Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage 28:244–249PubMedCrossRef
17.
Zurück zum Zitat Cassileth BR, Keefe FJ (2010) Integrative and behavioral approaches to the treatment of cancer-related neuropathic pain. Oncologist 15(Suppl 2):19–23PubMedCrossRef Cassileth BR, Keefe FJ (2010) Integrative and behavioral approaches to the treatment of cancer-related neuropathic pain. Oncologist 15(Suppl 2):19–23PubMedCrossRef
18.
Zurück zum Zitat Grealish L, Lomasney A, Whiteman B (2000) Foot massage: a nursing intervention to modify the distressing symptoms of pain and nausea in patients hospitalized with cancer. Cancer Nurs 23:237–243PubMedCrossRef Grealish L, Lomasney A, Whiteman B (2000) Foot massage: a nursing intervention to modify the distressing symptoms of pain and nausea in patients hospitalized with cancer. Cancer Nurs 23:237–243PubMedCrossRef
19.
Zurück zum Zitat Sturgeon M, Wetta-Hall R, Hart T, Good M, Dakhil S (2009) Effects of therapeutic massage on the quality of life among patients with breast cancer during treatment. J Altern Complement Med 15(4):373–380PubMedCrossRef Sturgeon M, Wetta-Hall R, Hart T, Good M, Dakhil S (2009) Effects of therapeutic massage on the quality of life among patients with breast cancer during treatment. J Altern Complement Med 15(4):373–380PubMedCrossRef
20.
Zurück zum Zitat Valtonen EJ, Lilius HG (1973) Syncardial massage in diabetic and other neuropathies lower extremities. Dis Nerv Sys 34:192–194 Valtonen EJ, Lilius HG (1973) Syncardial massage in diabetic and other neuropathies lower extremities. Dis Nerv Sys 34:192–194
21.
Zurück zum Zitat Ezzo J, Donner T, Nickols D, Cox M (2001) Is massage useful in the management of diabetes? A systematic review. Diabetes Spectrum 14(4):218–224. doi:10.2337 CrossRef Ezzo J, Donner T, Nickols D, Cox M (2001) Is massage useful in the management of diabetes? A systematic review. Diabetes Spectrum 14(4):218–224. doi:10.​2337 CrossRef
22.
Zurück zum Zitat Edwards BG, Palmer J (2010) Effects of massage therapy on African Americans with type 2 diabetes mellitus: a pilot study. Compl Health Pract Rev 15(3):149–155 Edwards BG, Palmer J (2010) Effects of massage therapy on African Americans with type 2 diabetes mellitus: a pilot study. Compl Health Pract Rev 15(3):149–155
23.
Zurück zum Zitat Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory. Cancer 89(7):1634–1646PubMedCrossRef Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory. Cancer 89(7):1634–1646PubMedCrossRef
24.
Zurück zum Zitat Castro-Sánchez AM, Moreno-Lorenzo C, Matarán-Peñarrocha GA, Feriche-Fernández-Castanys B, Sánchez Labraca N, Sánchez Joya Mdel M (2009) [Efficacy of a massage and exercise programme on the ankle-brachial index and blood pressure in patients with diabetes mellitus type 2 and peripheral arterial disease: a randomized clinical trial] [Article in Spanish]. Med Clin (Barc) 134(3):107–110, Epub 2009 Oct 12CrossRef Castro-Sánchez AM, Moreno-Lorenzo C, Matarán-Peñarrocha GA, Feriche-Fernández-Castanys B, Sánchez Labraca N, Sánchez Joya Mdel M (2009) [Efficacy of a massage and exercise programme on the ankle-brachial index and blood pressure in patients with diabetes mellitus type 2 and peripheral arterial disease: a randomized clinical trial] [Article in Spanish]. Med Clin (Barc) 134(3):107–110, Epub 2009 Oct 12CrossRef
25.
Zurück zum Zitat Sefton JM, Yarar C, Berry JW, Pascoe DD (2010) Therapeutic massage of the neck and shoulders produces changes in peripheral blood flow when assessed with dynamic infrared thermography. J Altern Complement Med 16(7):723–773PubMedCrossRef Sefton JM, Yarar C, Berry JW, Pascoe DD (2010) Therapeutic massage of the neck and shoulders produces changes in peripheral blood flow when assessed with dynamic infrared thermography. J Altern Complement Med 16(7):723–773PubMedCrossRef
Metadaten
Titel
Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage)
verfasst von
Joan Elizabeth Cunningham
Teresa Kelechi
Katherine Sterba
Nikki Barthelemy
Paul Falkowski
Steve H. Chin
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1231-8

Weitere Artikel der Ausgabe 9/2011

Supportive Care in Cancer 9/2011 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.